Compounding Pharmacy Products and Services at MEDISCA

Pediatric and Geriatric Compounding Laboratory Training

In this laboratory training, participants will be exposed to detailed procedures required to uphold exceptional compounding quality in the niche area of pediatric and geriatric therapy. With the implementation of innovative technologies and techniques, compounders will leave this course with the tools and knowledge needed to further their compounding practice.

No account yet? Register here to access.

ACTIVITY DESCRIPTION

Both pediatric and geriatric patients present with similar concerns regarding medication intake, most notably, difficulty in swallowing a tablet or capsule, or the requirement for a lower dosage strength than is commercially available. Such a challenge places compounding in high demand as a means to achieve alternate dosage strengths and dosage forms in order to meet the unique needs of these patient populations. The most common dosage form prescribed to pediatric and geriatric patients are oral liquids because they circumvent the challenges of swallowing a tablet or capsule and allow for flexible dosing. Alternatively, child-friendly dosage forms, such as gummies, offers a unique avenue that the compounding pharmacist can take.

FEATURED FORMULAS

Riboflavin 100 mg Oral Gummy Gels
Omeprazole 2 mg/mL Oral Liquid
Amlodipine Besylate 1 mg/mL Oral Liquid

Note: Formulas are subject to change.

DURATION: 4 HOURS

COMPLETION REQUIREMENTS

"Full attendance and participation is required to receive a Certificate of Attainment."

DECLARATIONS AND DISCLOSURES

This activity is independent of any known bias, prejudice or commercial interest. Both MEDISCA Australia and LP3 Network Inc. assist with the marketing of this activity. LP3 Network Inc. is an independent corporation. LP3 Network Inc. has an established agreement with MEDISCA Australia ensuring that it has no influence on LP3 Network Inc. as it relates to activity offerings.

FINANCIAL SUPPORT

This learning activity has received financial support from MEDISCA Inc. in the form of an educational grant.